Complimentary catering will be provided throughout the day, with time to connect and exchange ideas along the way. Those who wish can join us for an optional dinner.
Register now, places are limited. We look forward to welcoming you in Antwerp!
We're a mid-sized, full-service CRO specialized in early-phase development and biometrics. We offer drug development consultancy, project management, monitoring, data management, statistics, medical writing, safety and regulatory services. We have our own clinical pharmacology unit in Belgium featuring a viral challenge facility and have access to patients through our site network with 400+ sites. Our key therapeutic areas include infectious diseases, vaccines, respiratory, dermatology and oncology.
Guest
speakers
Will be
announced soon
Joris
De Bondt
Head EDC Biometrics
SGS
Jelle
Klein
Medical Director
SGS
You'll have the flexibility to create your own experience throughout the day. Choose the sessions, CPU-tour and 1-on-1 expert meetings that are most relevant to you and your challenges.
Dive into the topics that matter to you, with specialised sessions on clinical pharmacology, biometrics and pharmacovigilance.
Tailored presentations
Step inside our clinical pharmacology unit and see how a study works in practice. Explore our laboratories, volunteer facilities, GMP production facility, etc.
Behind the scenes tour
1-on-1 consultancy
Bring your questions to a 1-on-1 session with our experts in study design, regulatory, safety, biometrics, patient recruitment and bioanalysis.
Join us at SGS Pharma Connect for an exclusive gathering of pharma and biotech professionals and discover more about why Belgium is clinical research's best kept secret.
See how smarter study designs can accelerate the path from first-in-human to early proof-of-concept and beyond, while the right clinical development strategy helps reduce uncertainty and support better decisions from the very start.
Discover how AI can streamline eCRF study build and reduce manual work, while scalable biometrics solutions support growth from a single phase I study to an entire development programme.
Explore how safety monitoring differs in Human Viral Challenge Studies and how growing biotechs can build a pharmacovigilance framework that scales with an evolving clinical pipeline.
Full program coming soon
More sessions and speaker details will be announced shortly.